Vasopressin receptor antagonists (AVP antagonists) are a relatively new class of drugs that exert their effects by inhibiting one of three subtypes of vasopressin receptors. From: Pharmacology and Physiology for Anesthesia, 2024
What are Vasopressin antagonists? Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (
Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin; Vasopressin receptor antagonists: tolvaptan. Drugs that are strong CYP3A inducers:.
Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (antidiuretic hormone, ADH).
Antidiuretic Hormone Receptor Antagonists ; Tolvaptan Vasopressin V1a receptor, target ; Satavaptan Vasopressin V2 receptor, target ; Balovaptan Vasopressin
What are Vasopressin antagonists? Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (
Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin; Vasopressin receptor antagonists: tolvaptan. Drugs that are strong CYP3A inducers:.
Vasopressin antagonists or vasopressin receptor antagonists (VRA) are a new group of nonpeptide drugs used to treat hyponatremia.
Therapeutic potential of vasopressin receptor antagonists. Drugs. 2024; . PUBMED
Comments